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Abstract
Background: It is estimated that there are up to 1.1 million injection drug users (IDUs) in India; the majority are
likely married. We characterize HIV, hepatitis B (HBV) and hepatitis C (HCV) prevalence and the risk environment of
a sample of spouses of IDUs.
Methods: A cohort of 1158 IDUs (99% male) was recruited in Chennai, India from 2005-06. A convenience sample
of 400 spouses of the male IDUs in this cohort was recruited in 2009. A risk assessment questionnaire was
administered and a blood sample collected. Logistic regression was used to identify factors associated with
prevalent HIV.
Results: Median age was 31 years; thirteen percent were widowed and 7% were not currently living with their
spouse. Only 4 (1%) reported ever injecting drugs; Twenty-two percent and 25% reported ever using non-injection
drugs and alcohol, respectively. The majority had one lifetime sexual partner and 37 (9%) reporting exchanging sex.
Only 7% always used condoms with their regular partner. HIV, HBV and HCV prevalence were 2.5%, 3.8% and 0.5%,
respectively; among spouses of HIV+ IDUs (n = 78), HIV prevalence was 10.3%. The strongest predictor of HIV was
spousal HIV status (OR: 17.9; p < 0.001). Fifty-six percent of women had ever experienced intimate partner violence;
Eight-six percent reported sexual violence.
Conclusions: Our finding of a 10-fold higher HIV prevalence among spouses of IDUs compared with general
population women indicates their vulnerability; prevalence is likely to increase given the context of low condom
use and frequent sexual violence. Prevention efforts directed at IDUs should also include programs for spouses.
Background
Injection drug users (IDUs) are at high risk for HIV
acquisition and currently drive several of the fastest
growing HIV epidemics globally [1-4]. In India, the HIV
epidemic has historically been driven by heterosexual
transmission from initial reports among female sex
workers (FSWs) to eventual documentation of high HIV
prevalence among women who were married and mono-
gamous and reported no risk factors for HIV other than
sex with their husbands [5,6]. However, recent reports
have suggested stabilization of the heterosexual epi-
demic with decreasing prevalence and incidence among
FSWs and antenatal clinic attendees [7,8]. This is likely
in part due to interventions (e.g., condom promotion,
sexually transmitted infection [STI] testing) targeted
over the past decade at heterosexual high-risk popula-
tions including FSWs and truck drivers.
Concurrently, HIV epidemics among other risk groups
such as IDUs have continued to grow [6]. Though there
has been a wide range in the estimated size of the IDU
population in India due to use of different estimation
techniques, it has been suggested that up to 1.1 million
IDUs [1,4] may reside in India. In the early years of the
epidemic, HIV among IDUs in India was concentrated
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‘Golden Triangle’ - Burma, Laos, Thailand and Viet-
nam). However, it is now evident that IDUs exist in
most major metropolitan cities in India and have high
prevalence of HIV and associated blood-borne infections
(e.g., hepatitis B virus [HBV] and hepatitis C virus
[HCV]) [9-13]. Beyond transmission within drug using
networks, IDUs can also transmit HIV and other blood-
borne infections heterosexually because the majority are
married and sexually active [14-16]. Transmission to
wives and other sexual partners is likely facilitated by
low rates of condom use with regular sex partners
which has been previously reported among IDUs in
I n d i a[ 1 7 ] .T h u s ,t h ew i v e so fI D U sr e p r e s e n ta n o t h e r
group of married monogamous women who are at risk
for HIV and other infections primarily because of their
husband’s high risk behavior [18-20].
Prior studies in India have characterized the prevalence
of HIV among spouses of IDUs; a range of prevalence has
been observed from 5% in Chennai to 45% of those in
Manipur [14-16]. However, none of these studies charac-
terized prevalence of other bloodborne infections includ-
ing HBV and HCV. Further, few have characterized the
context of risk for these women; understanding their own
level of risk behavior, their economic situation and their
relationships with their husbands will provide a broader
understanding of their risk environment and will help to
design programs for this potentially vulnerable group [21].
Of particular interest is experienced intimate partner vio-
lence (IPV). Violence against women is recognized as a
global public health problem and can have adverse
impacts on physical, mental and reproductive outcomes
and can also increase risk for HIV [22-24]. A number of
studies have demonstrated high levels of IPV in India
[25-28], but few studies have characterized violence
among spouses of IDUs. As violence has been associated
with alcohol use [27], it is possible that experienced vio-
lence may be even greater in this population and can
further influence risk for HIV and other infections.
We previously characterized the prevalence of HIV,
HBV and HCV infection in a cohort of 1158 IDUs in
Chennai, India to be 25%, 11% and 65%, respectively
[29]. Almost two-thirds of the IDUs were married of
whom 40% were also sexually active. The objective of
this study was to characterize the prevalence of HIV,
HBV and HCV infections among a sample of the wives
of the IDUs in this cohort as well as to understand their
risk environment.
Methods
Study Population
Between April 2005-May 2006, 1158 IDUs were
recruited into a longitudinal cohort in Chennai, India
[29,30]. The Madras Injection Drug Users and AIDS
Cohort Study (MIDACS) operates through the YR Gai-
tonde Centre for Substance Abuse-Related Research
(YRGCSAR) in north Chennai. YRGCSAR was estab-
lished in November 2004 to provide HIV voluntary
counseling and testing (VCT) services to marginalized
populations and conduct longitudinal assessments of
HIV incidence and drug abuse among IDUs in Chennai.
A convenience sample of IDUs was recruited through
extensive community outreach as previously described
[29]. Briefly, field staff, who were predominantly former
IDUs, recruited participants from locales in all zones of
Chennai where IDUs were known to congregate (e.g.,
shooting galleries, drug treatment centers, etc.). Partici-
pants were eligible if they (1) provided written informed
consent, (2) were at least 18 years of age, and (3)
injected at least once in the prior 6 months by self-
report. Seven hundred and forty-five (64%) of the 1158
participants were married.
B e t w e e nJ u n ea n dA u g u s t2 0 0 8 ,w ec o n d u c t e df o u r
focus groups among male IDUs (n = 38) and four focus
groups among known spouses of male IDUs (n = 33) to
determine the best methods to recruit spouses of IDUs
into a research study. While greater than 75% of the
male IDUs were interested in their wives participating
in a study and receiving HIV testing, most were too
afraid to bring them in themselves. IDUs and their
spouses revealed that the majority of women married to
IDUs were aware that their husbands were injectors but
few were aware of their husband’s HIV serostatus. Most
IDUs wanted assistance in disclosing their HIV status to
their wives. This study provided them with an opportu-
nity for disclosure in a setting where couples counseling
w o u l db ea v a i l a b l e .B a s e do nt h i sf o r m a t i v ew o r k ,w e
adopted two methods of recruitment. IDUs in the
ongoing MIDACS were told that they could bring their
wives into the clinic for participation in the study. They
were assured that disclosure of any personal information
to their wives would only be done at their request and
consent. In addition, IDUs provided study staff with
contact information for their wives and these women
were approached directly by YRGCSAR staff. Study staff
have worked in the communities of North Chennai
since 1999 and have excellent rapport in this region
where the majority of MIDACS participants live. As the
recruitment of wives took place nearly three years after
enrollment of the IDU cohort and a high rate of mortal-
ity in this cohort (secondary to drug overdose, HIV and
tuberculosis) has been observed [31], 13% of IDUs were
dead by the time their wives were contacted. This study
was approved by the YRGCARE and Johns Hopkins
Bloomberg School of Public Health institutional review
boards.
The recruitment for the cross-sectional study took
place between April-November 2009. A convenience
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recruited (representing 54% of the wives of all married
IDUs in the MIDACS). Women were eligible to partici-
pate if they were ≥18 years of age, provided written
informed consent and reported having a husband who
had a history of injection drug use. To achieve the sam-
ple size of 400, 433 women were screened; thirty-three
(7.6%) did not consent. As all women were known
spouses of IDUs in the ongoing MIDACS, consent was
also obtained to link their HIV, HCV and HBV results
with those of their husbands who were enrolled in the
MIDACS. Even women who were recruited indepen-
dently provided identification information that per-
mitted linking their laborato r yd a t aw i t ht h e i rs p o u s e s
who were enrolled in MIDACS. However, behavioral
data from the MIDACS was not linked with the beha-
vioral data from this study as per the mandate of
the IRB.
Data collection
A blood sample was collected to test participants for
HIV, HBV and HCV and a risk assessment question-
naire was administered to all participants (additional file
1). HIV status was ascertained by testing for antibodies
to HIV by duplicate ELISA (Murex HIV-1.2.O, Abbott
Murex, UK and Vironostika
® HIV Uni-form II Ag/Ab,
bioMérieux, The Netherlands). Antibodies to HCV
(anti-HCV) were identified using the Murex Anti-HCV
kit (Abbott Murex, Republic of South Africa), and
chronic hepatitis B virus (HBV) infection was diagnosed
by the presence of hepatitis B surface antigen (HBsAg)
(Hepanostika HBsAg Uniform II, Biomérieux, The Neth-
erlands). All participants were provided with pre-test
counseling prior to collection of the blood specimen.
Additionally, participants were asked to return to
YRGCSAR two weeks later for results, post-test counsel-
ing and referrals for HIV care, if needed. The risk
assessment questionnaire collected information on
demographics, history of substance use (alcohol, non-
injection and injection drug use), sexual risk behavior
(including main and non-spousal partners, condom use
and commercial sexual encounters), intimate partner
violence (IPV) and perceived impact of drug use on the
family unit. Women were asked about their lifetime
experience with verbal, physical and sexual violence;
they were also asked to document the number of epi-
sodes of each in the prior six months. They were asked
about knowledge of their spouses drug use, HIV, HCV
and HBV status. Finally, they were asked to disclose all
of the ways in which their husband’s injection drug use
impacted their family (e.g., economic deprivation, nega-
tive influence on children, violence) and then to state
their primary concern about their husband’sd r u g
injection.
Statistical Analysis
Analyses presented are primarily descriptive. Dichoto-
mous/categorical variables are described as n (%) and
continuous variables as median (interquartile range
[IQR]). Univariate logistic regression was used to iden-
tify factors associated with prevalent HIV infection. As
only 10 women were infected with HIV, multivariate
analysis was not performed. All analyses were performed
using Intercooled STATA Version 10.1 (College Station,
Texas, USA).
Results
Description of population
The median age was 31 years (IQR: 26-36), the majority
were of Tamil ethnicity (97%) and had either no (28%)
or only primary-level education (62%). Eighty percent
were married and living with their spouse, 7% were liv-
ing away from their spouse and 13% were widowed
(Table 1). The median duration of marriage was
14 years (IQR: 7-19). The majority were employed and
earned daily wages. However, reported family income
was very low; sixty-seven percent reported an income of
less than INR 500 (10 USD) per month. Nearly all (99%)
reported that there were children and other family
members (in most cases their husbands’ parents) living
in the household.
Risk behavior
Only 4 women (1%) reported a history of injecting
drugs. Two of the four had injected in the prior six
months. Two reported injecting heroin and the other
two reported injecting buprenorphine. All reported
injecting with very good friends, but not with their hus-
bands. Twenty-six percent reported some alcohol use
but the majority reported drinking < once/week and
only 9 women reported daily alcohol use. Among the
102 women who reported any alcohol use, the most
commonly consumed beverages were brandy (50%) and
a combination of wine and beer (66%). Eighty-eight
women (22%) had ever used non-injection drugs. The
most common non-injection drug reported was smoke-
less tobacco (e.g., chewing tobacco products such as
mawa, zarda) followed by pharmaceutical drugs.
T h em a j o r i t y( 8 5 % )r e p o r t e do n l yo n el i f e t i m es e x u a l
partner; Fifty-two (13%) reported 2 sexual partners and
7 (3%) reported >2 partners with only 1 reporting more
than 4 partners (number of partners = 22) over their
lifetime. Thirty-seven (9%) reported having ever
exchanged sex for money or drugs. Of the 59 women
who reported multiple partners, 37 reported exchange
sex and 9 were widowed. Forty-nine (12%) had sex with
someone who was known to them to be HIV positive.
Condom use with both regular and non-regular partners
was infrequent (Table 1). Three-quarters (74%) reported
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and 70% reported never using condoms with their non-
regular partners.
Prevalence of HIV, HCV and HBV
Ten (2.5%) women were positive for HIV antibodies, 2
were positive for HCV antibodies (0.5%) and 15 (3.8%)
were positive for HBsAg. Of the 10 women who were
HIV positive, 8 (80%) had husbands who were also HIV
positive. All 10 reported currently living with their
spouse. Three reported two lifetime sexual partners and
the remaining 7 reported one. One reported a history of
exchange sex. Only three reported always using con-
doms with their primary partner and none reported
always using condoms with their non-regular partners.
None reported a history of injection drug use while
three reported some alcohol use and two reported some
non-injection drug use. HIV prevalence was significantly
higher among women whose husbands were also HIV
positive (10.2% vs. 0.6%, p < 0.001; Figure 1). Of the 14
who were HBsAg positive, only one had a husband who
w a sa l s oH B s A gp o s i t i v e .O ft h et w ow h ow e r eH C V
positive, one had a husband who was also HCV positive
and neither reported a history of injection. Five of the
10 HIV positive women were aware of their status; two
women reported a prior positive HIV test result but had
a negative antibody result in the study. Overall, 40% had
been tested for HIV at least once (Table 2). The major-
ity (94%) had never been tested for HBV or HCV.
Factors significantly associated with HIV prevalence
(Table 3) included more stable employment (odds ratio
[OR] for weekly/monthly wages vs. daily wages: 5.59;
95% confidence interval [CI]: 1.14, 7.27), higher family
income (OR for 500-1500 INR per month vs. < 500 INR
per month: 5.0; 95% CI: 1.09, 22.9), always using con-
doms with regular partner (OR: 9.13; 95% CI: 1.93,
43.2), having had sex with someone known to be HIV
positive (OR: 11.6; 95% CI: 3.15, 42.8) and having an
HIV positive husband (OR: 17.9; 95% CI: 3.73, 86.3).
Partner risk behavior
Three hundred and eight-six (97%) were not aware of
their husband’s injection drug use prior to marriage. Of
these, the majority (91.9%) learned their husbands were
IDUs when they saw them injecting at some point dur-
ing marriage. Eighty-two percent were aware of their
husband’s HIV serostatus but only 57.9% were aware of
their husband’s hepatitis status. Women who reported
being aware their husband was HIV positive were no
less likely to report sexual intercourse with their hus-
band in the prior six months compared to those who
Table 1 Description of study population: spouses of
injection drug users enrolled in Madras Injection
Drug User and AIDS Cohort Study, Chennai India,
2009 (n = 400)*
N = 400 (%)
Median age (years, IQR) 31 (26 - 36)
Tamil ethnicity 388 (97)
Education
None 110 (27.5)
Primary 246 (61.5)
> Primary 44 (11)
Current marital status
Married/living with spouse 318 (79.5)
Married/not living with spouse 28 (7)
Widowed 53 (13.3)
Median duration of marriage (years, IQR) 14 (7-19)
Employment status
Unemployed 24 (6)
Weekly/monthly wages 148 (37)
Daily wages 227 (56.8)
Family income (INR)
< 500 258 (66.7)
500-1500 72 (18.6)
>1500 57 (14.7)
Children living in household 399 (99.9%)
Alcohol use
Never 298 (74.5)
< 1/week 64 (16)
≥1/week 38 (9.5)
Ever used non-injection drugs 88 (22)
Marijuana 6 (1.5)
Smoked/chased brown sugar 7 (1.8)
Pharmaceutical drugs 41 (10.3)
Intoxicating tobacco 80 (20)
Ever injected drugs 4 (1)
Lifetime number of sexual partners
1 340 (85)
2 52 (13)
>2 7 (2.8)
Lifetime condom use with regular partner
Never 297 (74.3)
Sometimes 75 (18.8)
Always 27 (6.8)
Ever non-spousal sexual partner 37 (9.3)
Condom use with non-regular partner
Never 26 (70.3)
Sometimes 7 (18.9)
Always 4 (10.8)
Ever exchanged sex for money/drugs 37 (9.3)
Had sex with someone known to be HIV+ 49 (12.3)
*INR, Indian Rupees.
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their status (86.8% vs. 88.5% and 83.6% respectively, p =
0.53). However, among those who were sexually active
with their primary partner, those who thought their hus-
band was HIV positive were significantly more likely to
always use condoms than those who did not think their
husband was HIV positive or did not know their status
(15.2% vs. 0.4% and 3.3%, respectively, p < 0.0001).
Among those women who thought their husband was
HIV positive, 48% reported never using condoms in the
prior six months. Women who thought their husbands
were HIV positive reported better knowledge regarding
protection conferred by condoms against HIV (66% vs
53%, p < 0.01); however, thirty four percent of women
who thought their husband was HIV positive did not
know that condoms could protect against HIV. Women
who thought their husbands were HIV positive were sig-
nificantly more likely to have had an HIV test previously
vs. those who either thought their husband was negative
or did not know (64.2% vs. 24.1% and 28.8%, respec-
tively, p < 0.0001). Thirty-six percent of women who
were aware of their husbands HIV positive status had
never had an HIV test. Forty two percent of women
with an HIV positive husband felt that they could not
get HIV from their husband if he was not actively
injecting; this did not differ from those women who
did not have an HIV positive husband (39%, p = 0.9).
Other risk behaviors (e.g., exchange sex, alcohol use,
non-injection drug use) did not differ by whether their
partner was HIV positive.
When women were queried about the potential harm-
ful impact of their husband’s injection drug use, the pri-
mary fear was that he would get HIV/AIDS (36.7%),
followed by the impact on income for the family (33.2%)
and being a bad influence on their children (22.4%).
Intimate partner violence
Two hundred and twenty-two (55.5%) women reported
that they had ever experienced intimate partner violence
Figure 1 Prevalence of HIV, hepatitis C virus (HCV) and hepatitis B virus (HBV) among 400 wives of injection drug users by spousal
HIV status in Chennai, India (2009).
Table 2 HIV, HBV and HCV testing history among
spouses of injection drug users enrolled in the Madras
Injection Drug User and AIDS Cohort Study, Chennai,
India, 2009 (n = 400)
N = 400 (%)
Ever received an HIV test 122 (40.7)
Result of last test
Negative 87 (71.4)
Positive 7 (5.7)
Do not know/result not received 28 (23)
Prior testing for hepatitis viruses
Not tested for either 375 (94.2)
Tested for one but not sure which 10 (2.5)
Tested for hepatitis B only 1 (0.3)
Tested for hepatitis C only 0
Tested for both 10 (2.5)
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always occurred while their husband was under the
influence of alcohol and 90 (40.2%) reported that it
sometimes occurred while their husband was under the
influence of alcohol. Sixty-nine (30.8%) reported that
violence always occurred when their husband was under
the influence of drugs and 139 (62.1%) that it sometimes
occurred when their husband was under the influence of
drugs. Of the women who experienced violence, 98.2%
reported verbal violence, 96.4% reported physical vio-
lence (beaten/kicked/pushed/slapped by their spouse),
85.5% experienced sexual violence (forced to have sex
against their will) and 8.2% had been burned with a
cigarette. The overall proportion experiencing different
t y p e so fv i o l e n c ea n dt h ef r e q u e n c yi nt h ep r i o r
s i xm o n t h si si l l u s t r a t e di nF i g u r e2 .I nt h ep r i o r
six months, women experienced verbal violence a med-
ian of 348 times (IQR: 262 - 424), physical violence a
median of 186 times (IQR: 142-214) and sexual violence
a median of 76 times (IQR: 54-96).
Discussion
HIV prevalence among the spouses of IDUs in this sam-
ple in Chennai is about ten times higher than the preva-
lence of HIV among antenatal clinic attendees in Tamil
Nadu (0.25%) [6]. Prevalence of chronic HBV was also
high but HCV prevalence was comparable to the
expected general population prevalence. The low HCV
prevalence despite high prevalence of HIV and HBV
confirm that these women have little to no injection-
related risk of their own. It appears that the majority of
these women are married and monogamous with low
risk outside of unprotected sexual intercourse with their
husbands. This risk is compounded by the context in
which these women appear to be living; women were
subject to poverty and high levels of IPV including
forced sex particularly when their husbands were under
the influence of drugs and/or alcohol. These data
further substantiate the importance of including these
w o m e ni np r e v e n t i o na n dt r e a t m e n te f f o r t st or e d u c e
bloodborne infection transmission and IPV.
We observed a lower HIV prevalence among the
women in this study compared with what has been pre-
viously observed, particularly in the Northeast, but our
estimate was comparable to prior data from Chennai.
Chakrabarti and colleagues reported in 2000 that 45% of
the wives of 233 HIV-infected injectors in Manipur
were HIV positive [14]; Panda et al reported a preva-
lence of 5% among spouses of 226 married IDUs from
Chennai - 16% of the spouses of HIV-positive IDUs
tested positive for HIV antibodies [15]. The higher HIV
prevalence among the wives of IDUs in Manipur may
reflect an older HIV epidemic in the Northeast as well
as a higher prevalence of injection drug use among
w o m e ni nt h i sr e g i o nc o m p a r e dw i t ho t h e r s[ 3 2 ] .I n
both studies, the primary factor associated with HIV
aside from HIV/STI status of the partner was duration
of HIV infection in the husband [16]. HIV prevalence
among these women in Chennai will likely continue to
increase particularly given the setting of ongoing sexual
violence and low condom use even among women who
were aware of their husband’s positive HIV status.
These data further highlight the need for female-
controlled prevention measures.
Our study extends these other studies by including
data on HBV and HCV as well as more detailed charac-
terization of risk environment of these women. We
observed relatively low HCV prevalence (0.5%) which is
consistent with data that suggests that heterosexual
Table 3 Factors associated with prevalent HIV infection
among spouses of injection drug users enrolled in the
Madras Injection Drug User and AIDS Cohort Study,
Chennai, India, 2009 (n = 400)
Unadjusted OR (95% CI)
Age (per 10 years) 1.05 (0.69 - 1.60)
Education status
None 1
At least primary level education 1.54 (0.32 - 7.35)
Duration of marriage (per 5 years) 0.97 (0.63 - 1.50)
Employment status
Daily wages 1
Weekly/monthly wages 5.59 (1.14 - 7.27)
Employed 5.11 (0.45 - 58.7)
Family income (rupees)
< 500 1
500-1500 5 (1.09 - 22.9)
>1500 4.81 (0.95 - 24.5)
Alcohol use
None 1
< 1/week 0.66 (0.08 - 5.42)
≥1/week 2.29 (0.46 - 11.5)
Ever used non-injection drugs 0.88 (0.18 - 4.22)
Lifetime number of sexual partners
11
>1 2.55 (0.64 - 10.1)
Lifetime condom use with regular partner
Never 1
Sometimes 3.04 (0.67 - 13.9)
Always 9.13 (1.93 - 43.2)
Ever exchanged sex for money/drugs 1.06 (0.13 - 8.62)
Had sex with someone known to be HIV+ 11.6 (3.15 - 42.8)
HIV status of husband
Negative 1
Positive 17.9 (3.73 - 86.3)
Ever experienced sexual violence 0.47 (0.12 - 1.85)
*Results from logistic regression analysis; OR, odds ratio; CI; confidence
interval.
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tion was negligible among these women. By contrast,
the prevalence of chronic HBV infection was higher.
Interestingly, there was little concordance with the
HBsAg status of the spouse; however we did not have
information on all markers of HBV infection so it is
possible that some of their spouses were also infected
but had previously cleared (HBsAg negative but anti-
HBs positive).
The strongest correlate of HIV was husband’sH I V
serostatus. Our data are fairly consistent with prior
reports from India suggesting that these women have
relatively little risk of their own. Less than 1% had ever
injected, 85% were monogamous and a very small pro-
portion had more than 2 sexual partners. Though
37 women reported a history of exchanging sex for
money or drugs, only one woman reported more than
four partners. Not surprisingly condom use was extre-
mely low in this population reflecting general trends
among married couples in India [18-20]. The positive
association between condom use and HIV infection
likely reflects higher levels of condom use among those
who were aware of their HIV status as has been
previously observed in India and other settings [20,34].
Yet, it is important to note that even among the women
who were aware that their husbands were HIV positive,
consistent condom use was not universal and rates of
HIV testing were low.
Prior studies from India and South Asia have also sug-
gested low rates of condom use among similar groups of
women [16,17,35] and low testing rates [15,17]; however
few of these studies had information to link behavior
with women’s knowledge of their husband’ss e r o s t a t u s .
Therefore, it is particularly concerning that such beha-
viors were low even among those women who believed
their husband was infected. Future studies should explore
in more depth, possibly qualitatively, the reasons for
these low rates. Our data suggest that knowledge plays a
r o l eg i v e nt h a t3 3 %o fw o m e nw i t ha nH I Vp o s i t i v e
spouse did not know that condoms could protect against
HIV and 42% did not know they were at risk for HIV if
their husband was not actively injecting. Beyond knowl-
edge, the reasons for low condom use are likely multifac-
torial and include fear [36], the idea that unprotected sex
in long-term partnerships is a sign of intimacy and a
request for condom use a sign of distrust [17] and that
Figure 2 Prevalence of self-reported experienced intimate partner violence among 400 wives of injection drug users in Chennai, India
(2009). Bars represent percent ever experienced and lines represent median episodes (interquartile range [IQR]) of experienced violence in the
prior 6 months.
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region is unequally distributed by gender [37]. It is not
uncommon for women in south India (especially from
low income groups) to be subject to verbal/physical vio-
lence for suggesting condom use during sexual inter-
course with a primary partner [38]. As has been done in
other settings, interventions targeting IDUs need to focus
on issues beyond risks associated with needle sharing and
need to target their sexual partners. Drop-in centers and
voluntary counseling and testing (VCT) centers targeting
IDUs should include services for sexual partners (VCT,
condom distribution, targeted information, education
and communication (IEC) sessions), as has been recom-
mended by the World Health Organization, United
Nations Office of Drugs and Crime (UNODC) and
UNAIDS as a component of the comprehensive package
of services for IDUs [39].
Second to HIV/AIDS, the most pressing concern for
these women was the impact their husband’s drug use had
on income of the family. The median income reported by
the married IDUs enrolled in MIDACS was ~1500 INR
per month compared to a median 500 INR reported by
the spouses suggesting that IDUs might have been using a
large proportion of their income for drugs/alcohol. The
positive association between stable employment and HIV
may be further reflective of the strain placed on these
families. Husbands who are riskier (e.g., inject more fre-
quently) may consequently bring less income home for-
cing their wives to seek stable employment. Further, it is
also possible that women seek stable employment after
their husbands become ill with complications of HIV or
die as has been seen before in India [20]. Indeed 70% of
HIV positive women worked for weekly or monthly wages
vs. 37% of HIV negative women. Further, 13% of the
spouses of the women enrolled in this study died within
three years of enrolling in the MIDACS. It is possible then
that at least some of these women were forced to work to
support their families.
The economic adversity is further exacerbated by a
climate of violence and potentially fear. We observed
high levels of intimate partner violence, both physical
and sexual in this population. Sexual and physical vio-
lence have been previously reported to be common in
India [38]. While direct comparisons of prevalence are
difficult due to differences in definitions of physical and
sexual violence, the lifetime prevalence of sexual vio-
lence of 50% appears to be higher than other studies,
even those conducted in Chennai with other high risk
groups (e.g., men in wine shops) [25,26,28]. This likely
reflects the added effects of substance abuse in a popu-
lation where baseline levels of sexual violence are
already higher than normal. Even more alarming than
the lifetime prevalence of violence were the frequency of
recent episodes of both sexual and physical violence
suggesting that on average, violence occurs daily. Sexual
violence was not associated with higher HIV prevalence
but we were not able to perform multivariate analysis to
rule out negative confounding. Further, the lack of asso-
ciation may simply reflect the overall high prevalence of
sexual violence.
India is a strong patriarchal society and specific gen-
der roles are embedded deep within the culture. A key
role of men is to provide financially for their families.
When men are injecting drugs, this impacts their ability
to function in this role causing tremendous strain on
their wives and families. Women are somewhat power-
less in this situation as the majority of these women
marry without knowing about their husband’sd r u gu s e .
When they ultimately find out, it is too late for them to
change their situation as divorce is not commonplace in
Indian society, particularly in lower socioeconomic com-
munities. This situation appears to produce a volatile
environment, one in which resources are strained and
stability is thereby affected, leading to high levels of vio-
lence and disease transmission.
We were limited in this analysis by self-reported data,
which may be subject to social desirability, particularly
in this population where high-risk behavior is not nor-
mative. However, all participants were reassured regard-
ing confidentiality and all interviewers were women to
ensure the highest degree of comfort possible. Also, the
women were reassured that none of the information
shared with the interviewers would be relayed to their
husbands. Due to the cross-sectional nature of the
study, we were not able to establish temporal associa-
tions between exposures and HIV and other outcomes.
Indeed, some of the associations observed (e.g., HIV and
condom use) may reflect reverse causation. Further, the
small number of HIV infections (n = 10) prevented us
from conducting multivariate analysis. It is possible that
some of the associations we observed or did not observe
would have changed after accounting for confounding.
Conclusion
These data reinforce that HIV epidemics do not end with
the persons engaging in high-risk behaviors. Spouses of
IDUs represent another group of mostly monogamous
women in India who are placed at risk for HIV by the
behavior of their partners. Their risk context is further
strained by compromised economic resources and high
levels of intimate partner violence. Our data coupled with
other investigations support that HIV prevention and
treatment programs targeted at IDUs should also include
components directed at their families. Strategies to
empower these women are clearly needed; of particular
interest may be interventions that provide economic
opportunities for these women. Trials of pre-exposure
prophylaxis (PrEP) and female-controlled prevention
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Page 8 of 10tools such as vaginal microbicides should attempt to
recruit this population at high-risk for HIV acquisition.
In the meantime, while such novel tools await efficacy
demonstration, all programs providing services to IDUs
need to include services targeting wives/sexual partners
of IDUs (VCT, condom distribution, couples counseling,
etc.) as recommended by the WHO, UNAIDS and
UNODC.
Additional material
Additional file 1: Risk assessment questionnaire. This is the
behavioral survey that was administered to the 400 women in this study
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